Use of 1-(2-ethoxy-2-(3 min -pyridyl)ethyl)-4-(2 min -methoxy-phenyl)piperazine, or its enantiomers or pharmaceutically acceptable addition salts thereof, for the preparation of pharmaceutical compositions useful for the treatment of lower urinary tract disfunctions and benign prostatic hypertrophy.
展开▼